IP Library › Granted Patent US 10,744,090
Granted Patent B2
US 10,744,090 · App. 15/739,575 · Granted Aug 18, 2020

Multiphasic compositions

Inventors: Richard Wolf Garraway (Greater London, GB); William Henry (Greater London, GB)
Assignee: SEQUESSOME TECHNOLOGY HOLDINGS LIMITED
A61K9/1272A61K8/04A61K8/14A61K9/0014A61K9/10A61K9/127A61K31/155A61K31/165A61K31/355A61K31/522A61K31/60A61K31/618A61K31/7008A61K31/737A61K47/24A61K47/26A61P17/04A61P17/10A61Q19/00A61Q19/02A61Q19/08A61K33/30A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,744,090
App. No.
15/739,575
Granted
Aug 18, 2020
Kind
B2
Abstract

The present invention relates to compositions comprising a colloidal dispersion and an Agent of Interest (“AOI”), wherein the colloidal dispersion comprises deformable colloidal particles and wherein the AOI is not associated with the deformable colloidal particles. The present invention also provides kits and transdermal drug release devices comprising the compositions of the present invention, and the use of these compositions in medicine, skin care and cosmetics.

Claims (7)

1. A composition comprising a colloidal dispersion and an Agent of Interest (“AOI”), wherein said colloidal dispersion comprises deformable colloidal particles each comprising a surfactant and a phospholipid and wherein the AOI is a biologically active agent and comprises a chlorhexidine or a salt thereof and is not associated with the deformable colloidal particles, and further comprising a zinc tethered to the deformable colloidal particles.

2. The composition of claim 1 wherein the AOI comprises chlorhexidine digluconate.

3. The composition of claim 1 , comprising empty deformable colloidal particles.

4. The composition of claim 3 , wherein the composition comprises chlorhexidine digluconate, soy phosphatidylcholine, polysorbate 80 and one or more of butylhydroxyanisole, ethanol, zinc stearate, methyl-4-hydroxybenzoate (methyl paraben), ethyl-4-hydroxybenzoate (ethyl paraben), benzylalcohol, citric acid monohydrate, di-sodium hydrogen orthophosphate anhydrous, sodium hydroxide, carbopol 974P, glycerol and water.

5. The composition of claim 4 , wherein the chlorhexidine digluconate is present in the composition in the form of micelles.

6. The composition of claim 3 , wherein the deformable colloidal particles have a membrane mainly comprising soy phosphatidylcholine and polysorbate 80.

7. A method of treating or preventing acne or dermatitis, the method comprising topically applying the composition of claim 1 , to the skin of a patient in need thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2018
From: GARRAWAY, RICHARD WOLF; HENRY, WILLIAM
To: SEQUESSOME TECHNOLOGY HOLDINGS LIMITED
Reel/Frame 045065/0623 →
Priority Claims (2)
GB 1511469 · Jun 30, 2015 · national
GB 1511478 · Jun 30, 2015 · national
Continuity (1)
Related Publication 20180311148A1 · Nov 1, 2018